Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
Authors
Keywords
Atrial Fibrillation, Warfarin, Cardiac Tamponade, Activate Partial Thromboplastin Time, Activate Clotting Time
Journal
CLINICAL DRUG INVESTIGATION
Volume 33, Issue 6, Pages 409-418
Publisher
Springer Nature
Online
2013-04-09
DOI
10.1007/s40261-013-0081-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation
- (2012) Kenichi Kaseno et al. CIRCULATION JOURNAL
- Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation
- (2012) Greg Flaker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
- (2012) Dhanunjaya Lakkireddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Use of Dabigatran Immediately After Atrial Fibrillation Ablation
- (2011) ROGER A. WINKLE et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Deep Sedation for Catheter Ablation of Atrial Fibrillation: A Prospective Study in 650 Consecutive Patients
- (2011) HANS KOTTKAMP et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
- (2011) L. Samuel Wann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drug and dietary interactions of the new and emerging oral anticoagulants
- (2010) J. M. Walenga et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Remote Robotic Navigation and Electroanatomical Mapping for Ablation of Atrial Fibrillation
- (2009) Boris Schmidt et al. Circulation-Arrhythmia and Electrophysiology
- Atrial Fibrillation Ablation Strategies for Paroxysmal Patients
- (2009) Luigi Di Biase et al. Circulation-Arrhythmia and Electrophysiology
- Incidence and Predictors of Periprocedural Cerebrovascular Accident in Patients Undergoing Catheter Ablation of Atrial Fibrillation
- (2009) DANIEL SCHERR et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Femoral vascular complications following catheter ablation of atrial fibrillation
- (2009) Liza A. Prudente et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
- (2008) Stuart J. Connolly et al. CIRCULATION
- Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
- (2008) Pierre Jaïs et al. CIRCULATION
- Chronic Atrial Fibrillation Is a Biatrial Arrhythmia
- (2008) Thomas Rostock et al. Circulation-Arrhythmia and Electrophysiology
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate
- (2008) Joachim Stangier CLINICAL PHARMACOKINETICS
- Dabigatran Etexilate
- (2008) Mark Sanford et al. DRUGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started